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Abstract
Young people aged 15–24 years account for fifty percent of all new AIDS cases worldwide.
Moreover, half of all new HIV infections are associated with injection drug use. The average age for
initiation into injecting drug use is 20 years of age. This paper investigates whether HIV prevention
programs have reduced risk behaviours in young people.
Introduction
Young people are at the forefront of the HIV/AIDS epi-
demic as it continues to spread worldwide. An estimated
12 million people aged between 15 and 24 years are living
with HIV or AIDS around the world. Of the five million
new HIV infections in 2001, over half were among youth
aged 15–24 [1]. Six thousand young people become
infected with HIV every day, and over half of all new HIV
infections are related to injecting drug use [1]. In some
regions, such as Eastern Europe and Central Asia, nearly
all reported HIV infections are linked to drug injection,
the majority being young injectors. In some developing
and transitional countries, injection drug use is spreading
rapidly and the age of initiation of drug injecting is
decreasing [2].
Adolescence is an age when critical health behaviours are
established, including behaviours related to sex and drug
use (Ball, 2000). Most of these behaviors can be predicted
from the risk environment, with clusters of risk behaviour
being common, such as alcohol abuse and unprotected
sex, particularly among marginalised and vulnerable
youth. There is some evidence that young injectors think
and behave differently to older IDUs and are treated dif-
ferently within their communities. Specifically, young
IDUs have less knowledge about HIV/AIDS, have a lower
perception of their risk of acquiring HIV through either
drug injecting or sex, and are less likely to identify as being
an IDU than older IDUs [3].
Moreover youth have a heightened risk of HIV infection as
a result of many factors, including risky sexual behaviour,
substance abuse (including injecting drug use), and lack
of access to HIV information and prevention services. It is
crucial that barriers to accessing services that youth face
are recognized by youth health services, including pro-
grams to prevent HIV infection. Marginalized young peo-
ple, including homeless youth and ethnic minorities, may
be at an heightened risk due to factors such as stigma
(which may prevent access to critical HIV/AIDS informa-
tion and prevention programs), pressure to engage in
unprotected sex in exchange for food, shelter or money
and the use of illicit drugs. In an attempt to minimize the
HIV epidemic, a range of HIV interventions have been
developed [1]. These interventions are designed to change
behaviours of individuals who are at risk of acquiring or
transmitting HIV infection.
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Programs for young people offer the greatest potential for
changing the course of the epidemic [1]. However,
research into HIV prevention in youth is an area that has
seemingly been neglected, as most studies focus on adult
populations. This remains the case despite global findings
that injecting commences during adolescence [4].
Researchers need to redress this neglect of youth if they are
to produce evidence necessary to allow an effective global
health response.
Comparison of programs for effectiveness will allow rela-
tive judgments to be made regarding effectiveness, and
factors such as cost effectiveness can be taken into account
to assist in the allocation of resources, particularly in
resource-poor settings.
Calls for international standardisation have appeared in
the literature since at least 1999 [5]. According to Suishan-
sian et al [6] the need for standardisation, collection,
interpretation, and integration of program monitoring
data with biological and behavioural surveillance data on
HIV/AIDS associated with IDU is critical to informing and
guiding appropriate prevention responses.
The aim of this paper is to review recent literature of HIV
prevention programs for young injecting drug users
(IDUs) in an attempt to establish whether this call for
standardisation has been heeded by researchers and pro-
gram managers alike. Recommendations for improve-
ment in evaluations to allow comparisons is provided, to
assist in informing policy and program managers in the
development of evaluation designs.
Method
This review of the literature involved assessing the effec-
tiveness of HIV prevention programs for young, and new
injecting drugs users. The review also included programs
undertaken to prevent initiation of drug injecting and
transition from non-injecting to injecting drug use.
Databases such as Medline, Psychinfo, Web of Science,
Sociofiles, ERIC, Psychofiles and Aidsline were searched.
International and local websites of drug addiction and
prevention services or agencies and AIDS agencies and
libraries were examined. A similar search strategy was also
used to cover the grey literature. Unpublished literature,
such as conference presentations and agency reports, was
drawn from a number of different searches conducted on
the worldwide web.
Nonetheless, in order to evaluate the efficacy of the HIV
programs, only those that provided information regarding
the effectiveness of the outcome were included. Not sur-
prisingly, this somewhat restricted the number of studies
to be included.
Results
The comprehensive literature search found five HIV pre-
vention programs for young IDUs that met the criteria as
outlined above (see Additional file 1). More than fifty
studies were considered and five met the criteria to be
included in the study. The programs included were from
Australia [7,8] and the United States [9-11]. All five stud-
ies reported favourable HIV-related outcomes, although
inspection of Table 1 reveals the following discrepancies
between the studies:
All five studies aimed to reduce risk behaviours or
decrease incidence of HIV and other BBVIs. Biological out-
comes such as an objective measure of HIV/HCV sero-sta-
tus were absent in these studies. The outcome measured of
risk behaviour varied. One outcome measure was BBVI
knowledge, which was measured by a questionnaire pre
and post-intervention [8] as well as by evaluation feed-
back questionnaires [7]. A second outcome measure was
injecting risk practices, which was measure by self-report
questionnaires [8-10]. Each study employed differing
measures of injecting risk behaviours, such as using a new
needle/syringe at last injection, the number of sharing
partners and the frequency of needle/syringe sharing and
other injecting equipment sharing. A third outcome meas-
ure used in two studies was sexual risk practices, measured
by self-report questions. A fourth outcome used was fol-
lowing through with HIV-related health referrals, measured
by using self-report questions.
Further outcome measures were used as indicators of a
successful program rather than outcomes directly related
to changes in risk behaviours. Firstly participants' satisfac-
tion with the program was measured using focus groups
[7, 11 evaluation sheets [7], in an open-ended interview
[8,11]] and a structured interview [8]. Participants' per-
ception of the program's impact was measured by focus
groups and evaluation sheets [7] and structured and open-
ended interviews [8]. Lastly, service utilisation was meas-
ured. Participants' use of Harm Reduction Central's serv-
ices such as the needle exchange service was used as an
outcome measure by [11]. Service utilisation could also be
an indirect measure of reduced syringe sharing; if partici-
pants were using the needle exchange services to a greater
extent then they were likely to be sharing needles to a
lesser extent. Gleghorn et al. [9] included a measure of
Outreach Worker contact to determine the effect of differ-
ent levels of contact on injecting and sexual risk behav-
iours.
The target population varied in each of the HIV program
studies. Firstly the definition of a young person varied,
from under 26 years old to 12–23 years. However the
most common definition of youth in the literature is
between the ages of 15 and 24 years [4] although this def-Harm Reduction Journal 2005, 2:5 http://www.harmreductionjournal.com/content/2/1/5
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inition was used in only one program study [7]. Secondly
the definition of an injecting drug user varies, from those
at risk of commencing injecting to injecting more than
once a week. Thirdly the typical target population varied,
with some programs targeting specific cultural and socio-
economic subsets of the young IDU population, resulting
in difficulties in comparing the effectiveness between the
studies, as certain studies may vary in effectiveness
depending on the target population.
The sample sizes of the studies varied from 13 to 1,146
young IDUs. Sample size will impact on the statistical
power of the study. Small sample sizes are unlikely to
allow differences to be detected. Also, the assessment peri-
ods of the studies differed. Three studies were cross-sec-
tional [9-11] whereas others were longitudinal [7,8]. One
cross-sectional study [9] conducted measures pre-inter-
vention at the intervention site and at a comparison site.
Measures were then conducted during the program
(which was a continuous outreach program) at the pro-
gram site and two other comparison sites. One cross-sec-
tional study conducted measures during the program at
the intervention site and a comparison site only, and
another cross-sectional study conducted measures during
the program but without a comparison group. The study
conducted by Sheaves et al. [8] conducted measures pre
and post-intervention and at one-month follow-up but
was without a comparison group. The study conducted by
Maher et al. [7] conducted assessment post-intervention
and at 2-week follow-up, but was without baseline data
and a comparison group.
Conclusion
The United Nations aims to reduce HIV prevalence among
15–24 year olds by a quarter in the most affected countries
by 2005 and globally by 2010 [1]. For this to be possible,
youth require easy access to a wide range of effective HIV
prevention programs. They require information and skills
to help them adapt and maintain behaviours that are pro-
tective against HIV infection.
The studies presented in Table 1 employed disparate
methodologies, making a comparison of relative effective-
ness impossible. According to the authors, all studies had
some positive benefit for reducing HIV-related outcomes
in the sample, whether it be increasing participant knowl-
edge of HIV or other BBVIs or reducing needle and syringe
sharing. However, they all differed in outcomes measured,
instruments used, target population and study design.
Due to differences in the programs' nature and length and
other practical constraints such as budgetary factors, it is
unrealistic to expect a good level of consistency. Nonethe-
less, it is not unrealistic to expect better consistency than
that presented in Table 1 (see additional file 1). As out-
lined in the Introduction, standardisation is now recog-
nized as crucial and is in urgent need of implementation.
The need for standardisation still needs to be emphasised,
as standardized program findings are critical to informing
and guiding appropriate prevention responses [6]. More-
over, the push for standardized indicators which can be
compared across countries is necessary in order to deter-
mine which programs are effective in particular settings.
Furthermore it should be noted that all the studies in
Table 1 have come from research based in the US or Aus-
tralia. It is unclear whether the results from these coun-
tries can be applied to other countries.
The studies presented in Table 1 only measured behav-
ioural outcomes and did not contain biological data. Bio-
logical data (HIV seroincidence for example, conducted
by [12]) are an objective way of determining the effects of
a prevention program. However, conducting a large-scale
study with HIV serology, large enough to detect a noticea-
ble effect between the intervention and control group
would be costly and may not be feasible. Other objective
data that could be used as outcome measures are service
utilization measures such as those used by Weiker et al.
[11]. It could be inferred, for example, that an increase in
syringe distribution at a Needle and Syringe Program may
be an indicator of a reduction in needle sharing or a reduc-
tion in the time syringes remain in circulation. As self-
report data have the problems of recall bias and social
desirability, combining these data with biological and/or
service utilization data would improve the evidence of the
effectiveness of a prevention program.
The studies presented in Table 1 additionally lack cost-
benefit data, crucial information to aid policy makers and
program managers in allocating resources, particularly in
resource poor settings. Random sampling was not con-
ducted in any of the studies, thus biases in the results may
exist. Although random sampling of individuals in one
location for example may not be feasible, random alloca-
tion of the intervention to certain clinics may be one solu-
tion. Two studies did conduct assessments at an
intervention site as well as one or more comparison sites,
although these studies did not measure the same partici-
pants pre and post intervention, and so were unable to
determine the effect of the prevention program on HIV-
related outcomes. These short comings resulted in less
conclusive data. However the desire to obtain accurate
information and the costs and practical issues in collect-
ing such information need to strike a balance and
although the ideal should be strived for, it is not always
possible. Another reason for the lack of research on youth
has been the restrictions imposed by many ethics commit-
tees on researchers accessing young people.Harm Reduction Journal 2005, 2:5 http://www.harmreductionjournal.com/content/2/1/5
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UNAIDS proposes that HIV prevention programs for
youth should have the following characteristics for effec-
tiveness:
• To succeed they should respect and involve young peo-
ple, while being sensitive to their cultures.
• Young people need a safe and supportive environment,
with sensitive attitudes, policies and legislation at family,
community and national levels.
• The stigma and discrimination associated with HIV/
AIDS needs to be diffused.
• Strong and effective education systems are important,
yet in many countries education systems are clearly in dis-
array.
• Outreach and peer education programs among young
drug users should be expanded, and include steps to
improve access to information and prevention equipment
such as condoms and needles and syringes and HIV/AIDS
care services.
Upon searching the literature for recommendations of
standardized instruments and study designs to integrate
in a new evaluation study of a HIV prevention program,
no clear guidelines were found. If standardised, valid and
reliable instruments were in the literature, then program
managers would be more likely to adopt them in practice.
An important confounding concern is that although
standardized indicators are needed that can be compared
across countries and regions of the world, failure to adapt
these indicators to the local setting can weaken our ability
to obtain valid information. Key experts in the field need
to make clear recommendations of evaluation study
design and instruments to use, preferably at a global level.
The following recommendations are a result of this
review, with respect to study design, outcomes and instru-
ments to use:
(1) Randomise (at clinic level or individual level)
(2) Collect baseline, post-intervention and follow-up data
on the same clients
(3) Use control or comparison group
(4) Collect behavioural and biological data
(5) Use standardized instruments to measure HIV out-
comes.
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